MariMed Inc. (MRMD) Tops Q4 EPS by 221c

MariMed Inc. (OTC: MRMD) reported Q4 EPS of $2.20, $2.21 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $41.7 million versus the consensus estimate of $40.8 million.

For earnings history and earnings-related data on MariMed Inc. (MRMD) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Stifel on EyePoint Inc. (EYPT): 'we think these data bode well for LUCIA (expected October) barring another unusual asymmetry'
• Is Treasury selloff a major issue for stock market bulls?